2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
- 20 April 2015
- journal article
- review article
- Published by Elsevier BV in Annals Of Oncology
- Vol. 26 (8), 1573-1588
- https://doi.org/10.1093/annonc/mdv187
Abstract
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11–12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease.Keywords
This publication has 108 references indexed in Scilit:
- Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' dataThe Lancet Oncology, 2013
- Sleeve lobectomy versus pneumonectomy for non-small cell lung cancer: a meta-analysisWorld Journal of Surgical Oncology, 2012
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410JNCI Journal of the National Cancer Institute, 2011
- Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214Journal of Clinical Oncology, 2011
- European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung CancerJournal of Clinical Oncology, 2010
- Improving Radiation Conformality in the Treatment of Non–Small-Cell Lung CancerSeminars in Radiation Oncology, 2010
- Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient dataThe Lancet, 2010
- Radiation Dose–Volume Effects in the LungInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative GroupJournal of Clinical Oncology, 2008
- Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)European Journal Of Cancer, 2007